A 2025 study by Wang, Sizhang and colleagues at Nature explores critical biomarkers linked with M1 macrophages in HER2-positive breast cancer. The research integrates machine learning to identify gene targets, providing a useful framework for optimizing immunotherapy. This work offers new strategies for patient assessment and treatment refinement.